RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN'S ONCOHEMATOLOGICAL DIVISION

The article provides an analysis of using medications in children's oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblast...

Full description

Saved in:
Bibliographic Details
Main Authors: Z.A. Maevskaya (Author), R.N. Luchinina (Author), I.E. Gerbek (Author), Yu.P. Chasovskikh (Author), I.Yu. Smirnova (Author), О.М. Fal'kovich (Author)
Format: Book
Published: Union of pediatricians of Russia, 2010-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e48646848bf9482a936ba5407406cb15
042 |a dc 
100 1 0 |a Z.A. Maevskaya  |e author 
700 1 0 |a R.N. Luchinina  |e author 
700 1 0 |a I.E. Gerbek  |e author 
700 1 0 |a Yu.P. Chasovskikh  |e author 
700 1 0 |a I.Yu. Smirnova  |e author 
700 1 0 |a О.М. Fal'kovich  |e author 
245 0 0 |a RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN'S ONCOHEMATOLOGICAL DIVISION 
260 |b Union of pediatricians of Russia,   |c 2010-05-01T00:00:00Z. 
500 |a 1727-5776 
500 |a 2500-3089 
520 |a The article provides an analysis of using medications in children's oncohematological department in Tomsk in 2008. Over that period 52 children aged from 6 months to 18 years were treated (with an acute lymphatic leukaemia, lymphogranulomatosis, non Hodgkin lymphom, acute and chronic myeloblastic leukemia, etc.). According to АВС/VEN analysis, 79,9% of funds was spent on acquisition of 11 group A medications, 15,1% - on group B medications, 5% - on group C medications. Vital medications (V) accounted for 79,4%, essential medications (Е) - 14,7%, non-essential medications (N) - 5,9%. The authors examined the toxicity of vincristine depending on manufacturers. Key words: children, malignant blood diseases, ABC/VEN analysis, vincristine, neurotoxicity. (Pediatric Pharmacology. - 2010; 7(3):14-16) 
546 |a RU 
690 |a Pediatrics 
690 |a RJ1-570 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Педиатрическая фармакология, Vol 7, Iss 3, Pp 14-16 (2010) 
787 0 |n https://www.pedpharma.ru/jour/article/view/1137 
787 0 |n https://doaj.org/toc/1727-5776 
787 0 |n https://doaj.org/toc/2500-3089 
856 4 1 |u https://doaj.org/article/e48646848bf9482a936ba5407406cb15  |z Connect to this object online.